PCN18 Matching-Adjusted Indirect Comparison (MAIC) of Entrectinib Versus Crizotinib in Patients with ROS1 NON-SMALL CELL LUNG Cancer (NSCLC): An Updated Analysis

Dec 1, 2020, 00:00 AM
10.1016/j.jval.2020.08.155
https://www.valueinhealthjournal.com/article/S1098-3015(20)32411-6/fulltext
Section Title :
Section Order : 10114
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32411-6&doi=10.1016/j.jval.2020.08.155
HEOR Topics :
Tags :
Regions :